Completed Cells, Biochemistry & Physiology Genetics & Molecular Biology

Protein crystallography: development of new methods, and application to the study of pathogenesis.

In plain English

AI plain-English summary

A new computer program called Phaser will use statistical methods to solve the three-dimensional shapes of proteins with less prior information than currently possible. This matters because knowing a protein’s precise structure is often the key to understanding how it works—and how it goes wrong in disease. The current methods for solving these structures are slow and require extensive prior knowledge, which limits how many disease-relevant proteins can be studied. The researchers aim to make the process faster and more flexible, using smaller molecular fragments or even models built from scratch. If successful, the work could accelerate the design of better treatments for several diseases. The team will apply their methods to three specific problems: the enzymatic mechanism of pertussis toxin (whooping cough), the targeted release of hormones by binding globulins (which could be adapted to deliver drugs to specific sites in the body), and enzymes that are faulty in lysosomal storage diseases—rare genetic disorders where toxic materials build up in cells. The ultimate goal is to improve enzyme replacement therapy for these patients. The project combines fundamental method development with direct application to disease. The new crystallographic tools themselves will be made available to the wider research community.

View original technical description
The proposed research is in the area of protein crystallography, involving both the development of new methods, and applications to the study of proteins relevant to disease. Crystallographic methods in our new computer program Phaser are based on the principle of maximum likelihood, which requires an understanding of the statistical relationships among experimental observations. We will build on success in the area of molecular replacement to solve structures with less prior knowledge, usin g either smaller fragments or ab initio models. We will complete the implementation of experimental phasing by multiple-wavelength isomorphous replacement and two-wavelength anomalous diffraction, and we will explore other applications, for instance to phasing in the presence of radiation damage. In our structural research, we will complete our study of the enzymatic mechanism of pertussis toxin by determining structures representing the Michaelis complex. We will study the mechanism by whi ch the hormone-binding globulins carry out a targeted release of bound hormone, and will attempt to exploit that understanding to design variants that release selected drugs at selected target sites. Finally, we will begin a new study on enzymes mutated in lysosomal storage diseases, with the eventual goal of contributing to improvements in enzyme replacement therapy.

View the original record at the funder ↗

Researchers

Randy Read (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Accounting for correlated errors with maximum likelihood in crystallography and cryo-EM
CCP4 Grant Renewal 2014-2019: Question-driven crystallographic data collection and advanced structure solution
Cryo-EM for understanding molecular processes in health and disease
High-throughput low-volume crystallisation facility
Mining of protein data bank and feedback to X-ray crystal structure solution and analysis

Original classification

Principal Research Fellowship Renewal

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.